Exploring the role of host immunogenetics in susceptibility to severe COVID-19 to identify novel targets for disease prevention and treatment
- Funded by Novo Nordisk Foundation
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AKnown Financial Commitments (USD)
$1,583,659.44Funder
Novo Nordisk FoundationPrincipal Investigator
Trine MogensenResearch Location
DenmarkLead Research Institution
Aarhus UniversityResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnosticsResearch Subcategory
Pathogen genomics, mutations and adaptationsSpecial Interest Tags
N/AStudy Type
UnspecifiedClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicable